Geltor is the biodesign company that has created the world's largest selection of designer proteins, with unprecedented biocompatibility, functionality and benefits for consumers.
Geltor audaciously imagines and deeply explores all the possibilities that the tree of life has to offer.
Geltor was founded in 2015 by Alexander Lorestani and Nick Ouzounov. The company is headquartered in San Leandro, California.
Geltor has created the largest selection of designer proteins that are crafted with unparalleled biocompatibility and functionality. These proteins are 100% animal- and GMO-free, globally scalable, and sustainably cultivated. Geltor’s products are the result of endless curiosity and ceaseless optimization, clinically demonstrated for high performance.
Geltor has proven its biodesign technology for large and growing global CPG segments including cosmetics & personal care, nutraceuticals, and the food & beverage industries. Its success across global CPG segments reflects consumers' increasing preference for ethical products, as more brands face backlash for using animal ingredients and contributing to the growing threat of climate change.
Geltor is backed by CPT Capital, Blue Horizon Ventures, RIT Capital Partners, WTT Investment Ltd., Cultivian Sandbox, SOSV, iSelect Fund and others. The company closed its Series B round with $91.3M on Jul 27, 2020. This brings Geltor's total funding to $116.3M to date.